FIASP: payments to doctors
Payments that named FIASP as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $46K
- Providers
- 124
- Transactions
- 162
- Average per transaction
- $285
The per-transaction average — $285 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 124 providers the average total is $372, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novo Nordisk | $37,949 | 82.3% |
| Novo Nordisk AS | $8,143 | 17.7% |